What are the 12-month event rates for unstable angina?

Updated: Oct 01, 2020
  • Author: Walter Tan, MD, MS; Chief Editor: Eric H Yang, MD  more...
  • Print

A contemporary large clinical trial with centrally adjudicated outcomes showed that an ACS portends more adverse events in the year to come. [21] The following are the 12-month event rates for the ACS patients (final diagnosis of unstable angina, 16.6%; NSTEMI, 42.9%; STEMI, 37.5%), whose median age was 62 years, 25% of whom were diabetic, and fewer than 1% of whom were classified as above Killip class 2 [21] :

  • Death from vascular causes - 4.3%

  • Death from nonvascular causes - 0.6%

  • MI - 5.9%

  • Stroke - 1.2%

These findings present an opportunity for secondary prevention of such adverse events.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!